UBS Group’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-28
Closed -$84 9181
2024
Q3
$84 Sell
28
-7,707
-100% -$23.1K ﹤0.01% 7959
2024
Q2
$22.6K Buy
7,735
+5,788
+297% +$16.9K ﹤0.01% 6077
2024
Q1
$6.67K Sell
1,947
-3,655
-65% -$12.5K ﹤0.01% 6275
2023
Q4
$16.2K Buy
5,602
+890
+19% +$2.57K ﹤0.01% 6025
2023
Q3
$13.1K Buy
+4,712
New +$13.1K ﹤0.01% 5861
2023
Q2
Sell
-624
Closed -$1.72K 8540
2023
Q1
$1.72K Buy
+624
New +$1.72K ﹤0.01% 7562
2022
Q4
Sell
-4,048
Closed -$14K 9886
2022
Q3
$14K Buy
+4,048
New +$14K ﹤0.01% 6839
2022
Q2
Sell
-198
Closed -$1K 9836
2022
Q1
$1K Buy
+198
New +$1K ﹤0.01% 8893
2021
Q4
Sell
-750
Closed -$9K 9479
2021
Q3
$9K Buy
750
+206
+38% +$2.47K ﹤0.01% 6977
2021
Q2
$15K Buy
+544
New +$15K ﹤0.01% 6558
2020
Q3
Sell
-402
Closed -$9K 7445
2020
Q2
$9K Sell
402
-742
-65% -$16.6K ﹤0.01% 6245
2020
Q1
$21K Buy
1,144
+998
+684% +$18.3K ﹤0.01% 5566
2019
Q4
$17K Buy
146
+68
+87% +$7.92K ﹤0.01% 5937
2019
Q3
$7K Sell
78
-188
-71% -$16.9K ﹤0.01% 6386
2019
Q2
$15K Sell
266
-287
-52% -$16.2K ﹤0.01% 5941
2019
Q1
$27K Buy
+553
New +$27K ﹤0.01% 5220
2018
Q3
Sell
-94
Closed -$3K 7211
2018
Q2
$3K Buy
94
+73
+348% +$2.33K ﹤0.01% 6727
2018
Q1
$1K Sell
21
-369
-95% -$17.6K ﹤0.01% 6776
2017
Q4
$18K Buy
+390
New +$18K ﹤0.01% 5669
2017
Q1
Sell
-69
Closed -$4K 6863
2016
Q4
$4K Buy
69
+47
+214% +$2.73K ﹤0.01% 6360
2016
Q3
$2K Buy
+22
New +$2K ﹤0.01% 6481
2016
Q2
Sell
-75
Closed -$5K 6951
2016
Q1
$5K Buy
75
+39
+108% +$2.6K ﹤0.01% 6154
2015
Q4
$4K Buy
36
+3
+9% +$333 ﹤0.01% 6403
2015
Q3
$4K Sell
33
-2
-6% -$242 ﹤0.01% 6388
2015
Q2
$5K Buy
+35
New +$5K ﹤0.01% 6294
2015
Q1
Sell
-28
Closed -$7K 6822
2014
Q4
$7K Buy
+28
New +$7K ﹤0.01% 6199